申请人:NURIX THERAPEUTICS, INC.
公开号:US20220143195A1
公开(公告)日:2022-05-12
The present invention relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.